ZNF568 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.641200E-01
Normal-vs-Stage2
3.230000E-01
Normal-vs-Stage3
3.545600E-02
Normal-vs-Stage4
9.821400E-01
Stage1-vs-Stage2
3.215200E-01
Stage1-vs-Stage3
1.356230E-01
Stage1-vs-Stage4
8.764400E-01
Stage2-vs-Stage3
1.661770E-01
Stage2-vs-Stage4
2.448400E-01
Stage3-vs-Stage4
1.291190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.391800E-01
Normal-vs-AfricanAmerican
9.668800E-01
Normal-vs-Asian
3.395800E-01
Caucasian-vs-AfricanAmerican
4.204600E-01
Caucasian-vs-Asian
5.553800E-01
AfricanAmerican-vs-Asian
2.544000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.037400E-01
Normal-vs-Female
6.114000E-01
Male-vs-Female
2.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.861800E-01
Normal-vs-Age(41-60Yrs)
6.904000E-01
Normal-vs-Age(61-80Yrs)
5.046000E-01
Normal-vs-Age(81-100Yrs)
9.467900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.531800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.425800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.762800E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.306620E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.512100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.381600E-01
Normal-vs-Daily Drinker
6.854200E-02
Normal-vs-Weekly Drinker
4.156200E-01
Normal-vs-Occasional Drinker
9.092000E-01
Normal-vs-Social Drinker
8.621600E-01
Non Drinker-vs-Daily Drinker
6.604000E-01
Non Drinker-vs-Weekly Drinker
2.377600E-01
Non Drinker-vs-Occasional Drinker
6.988000E-02
Non Drinker-vs-Social Drinker
1.368610E-01
Daily Drinker-vs-Weekly Drinker
1.196410E-01
Daily Drinker-vs-Occasional Drinker
3.983600E-02
Daily Drinker-vs-Social Drinker
8.761900E-02
Weekly Drinker-vs-Occasional Drinker
4.126200E-01
Weekly Drinker-vs-Social Drinker
5.156200E-01
Occasional Drinker-vs-Social Drinker
9.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.986000E-01
Normal-vs-Grade 2
2.956600E-01
Normal-vs-Grade 3
3.048600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.532400E-01
Grade 1-vs-Grade 3
2.669000E-01
Grade 1-vs-Grade 4
3.986000E-01
Grade 2-vs-Grade 3
9.856200E-01
Grade 2-vs-Grade 4
2.956600E-01
Grade 3-vs-Grade 4
3.048600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.667200E-01
Normal-vs-NonDiabetic
5.381200E-01
Diabetic-vs-NonDiabetic
8.209800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.370200E-01
Normal-vs-NoPancreatitis
5.334600E-01
Pancreatitis-vs-NoPancreatitis
5.273400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.593200E-01
Normal-vs-N1
3.460800E-01
N0-vs-N1
3.867200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.746000E-01
Normal-vs-TP53-NonMutant
9.328600E-01
TP53-Mutant-vs-TP53-NonMutant
2.247700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
